Simeox

Innovation in Airway Clearance

Simeox

Which patients

For patients with a viscous and thick mucus, for whom the mucociliary process is impaired – among which cystic fibrosis patients and chronic obstructive pulmonary diseases (COPD) patients.

Key benefits to patients

Efficient and Comfortable Bronchial Drainage

  • Direct action on mucus rheology to decrease secretion viscosity
  • lmproved mucus transport and drainage from the distal areas of the lungs
  • No increase of the physiological collapse of the bronchi
  • Decreased thoracic distension
  • Patient’s energy is preserved as he remains relaxed while using Simeox
  • Flexibility in managing bronchial drainage on daily basis

Simeox

Simeox

Graphic Interface

Thanks to the touchscreen interface, the patient benefits from the real-time visualization of the progress of his/her treatment via the device internal sensors.

This biofeedback allows to:

  • Include the patient in a therapeutic program,
  • Encourage the patient to evolve and progress,
  • In the future, move to tele-monitoring and data analysis.

Sounds interesting?

Organize a free trial about the Simeox system today!

Get your demo